Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001213900-13-002615
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | -$689.03K | -$908.91K |
| EPS Diluted | -$0.03 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
